Title: Aarkstore - The Cancer Drugs & Treatments Market - Data, Analysis & Forecasts to 2023
1Aarkstore - The Cancer Drugs Treatments
Market - Data, Analysis Forecasts to 2023
Category Healthcare
2Aarkstore - The Cancer Drugs Treatments Market
- Data, Analysis Forecasts to 2023
3Summary
- GMR Data forecast that the global cancer drugs
and treatments market will reach 143.7bn by
2023. GMR Datas latest report The Cancer Drugs
Treatments Market - Data, Analysis Forecasts to
2023 explains just how this market will
experience growth over the medium and long term.
The report also highlights forecast for the next
5 and 10 years, so that you and your company can
make specific long term plans. Dont let your
competitors get the head-start on you, order this
report today. - Have you seen the recent news on Cancer Drugs?
- - Mercks new cancer drug kept more than
4 of 5 melanoma patients alive for a year - - Biopharma Alliances will be needed For
Cancer Drugs in the cost conscious future
Forbes - - EU approval for Bayers prostate cancer
drug - - Sanofi ditches late-stage bone marrow
cancer drug -
4The Anti-cancer treatment market is already worth
77.4bn (GMR Data) and continues to be one of
the largest and fastest growing areas for new
drug development can you afford not to be
involved? Should you and your company be
capturing a greater market share? Essential
facts examined in this report 1) Across
2013, 15 new molecular entities were approved by
the FDA out of which seven were for
Oncology. 2) Currently targeted therapies
dominate the oncology pipeline, followed by
chemotherapy. 3) Immunotherapy drugs are
gaining increasing amounts of attention due to
fewer expected side effects.
5Table of Contents
- 1. Executive Summary
- 2. Chapter 2 Types of Cancer Causes, symptoms
and global prevalance of the key cancers
affecting the worlds population - Chapter 3 Cancer Causes Effects - Which
factors effect the causes of cancers, globally. - Chapter 4 Cancer Treatment Types Side Effects
- Chapter 5 Cancer Therapies / Drugs Market
Forecast - Chapter 6 Cancer RD Pipeline and Drugs
- Chapter 7 Major Trends Challenges in the Global
Cancer Drugs Market - Chapter 8 Regional Landscape The Key Global
Cancer Drug Markets - Chapter 9 Major Players in the Oncology Market
- 10.1 Dr John Marshall, Clinical Director of
Oncology, Georgetown University Hospital -
6List Of Tables
- Table 2.1.1.1 Major Drugs in Blood Cancer Market
- Table 2.1.2.1 Major Bone Cancer Drugs in the
Market - Table 2.1.3.1 Major Brain Cancer Drugs in Market
- Table 2.1.4a Breast Cancer Incidences in US UK
- Table 2.1.4b Major Breast Cancer Drugs in Market
- Table 2.1.5 Major Gastrointestinal Cancer Drugs
in Market - Table 2.1.6 Major Endocrine Cancer Drugs in
Market - Table 2.1.7 Major Eye Cancer drugs In the Market
- Table 2.1.8 Major Genitourinary Cancers Cancer
drugs In the Market - Table 2.1.9 Major Gynaecologic Cancer drugs In
the Market - Table 2.1.10a Head Neck Incidences in Asian
Region - 2008 -
7List Of Figures
- Figure 2.1.1.1 Blood Cancer Type Incidences
- Figure 2.1.2.1 Global Breakdown of types of Bone
Cancer - Figure2.1.11 Global Market Size as per Lung
Cancer Type Incidences - Figure 2.1.12 Global Market Size as per Skin
Cancer Type Incidences - Figure2.2.1a Global Cancer Market as per
Incidences - Figure2.2.2a Global Cancer Market by Mortality
Survival - Figure 5.1.a Global Targeted Therapy Market for
Cancer Treatment 2008-2012 - Figure 5.1.b 2012 Targeted Therapy Market by
Major Drugs - Figure 5.1.c 2012 Other Targeted Therapy Drugs
Market Share - Figure 5.1d Global Targeted Therapy Market for
Cancer Treatment 2013-2023 -
8Related Reports
- Generic Drugs Market in Japan 2015-2019
- Lung Cancer-Global API Manufacturers, Marketed
and Phase III Drugs Landscape, 2015 - Metastatic Brain Tumor-Global API Manufacturers,
Marketed and Phase III Drugs Landscape, 2015 - Lupus Erythematosus-Global API Manufacturers,
Marketed and Phase III Drugs Landscape, 2015 - Metastatic Breast Cancer-Global API
Manufacturers, Marketed and Phase III Drugs
Landscape, 2015
9Related Reports
- Malaria-Global API Manufacturers, Marketed and
Phase III Drugs Landscape, 2015 - Metastatic Colorectal Cancer-Global API
Manufacturers, Marketed and Phase III Drugs
Landscape, 2015 - Melanoma-Global API Manufacturers, Marketed and
Phase III Drugs Landscape, 2015 - Metastatic Hormone Refractory (Castration
Resistant, Androgen-Independent) Prostate
Cancer-Global API Manufacturers, Marketed and
Phase III Drugs Landscape, 2015 - Pharmaceuticals Healthcare Market Research
Reports
10The Cancer Drugs Treatments Market - Data,
Analysis Forecasts to 2023 Published Nov 2013
247 Pages GMR Data forecast that the global
cancer drugs and treatments market will reach
143.7bn by 2023. GMR Datas latest report
Format Price
PDF 999
Site License 3599
Enterprise Wide Licence 8499
11Contact Us
- Office
- Office No. - 809, 8th Floor,
- B-Wing, Mahaavir Icon,
- Plot No.- 89 90, Sector-15,
- CBD-Belapur, Navi Mumbai 400614,
- Maharashtra, India.
- Telefax No 91 22 4127 6660
- 24/7 Online Support 91 9987295242
- General Inquiries 91 - 22 2756 4953
- You Can Visit
- http//www.aarkstore.com
- OR Mail us at
- contact_at_aarkstore.com
- Blog
- http//www.aarkstore.com/blog/
- Conference
- http//conference.aarkstore.com/
- News
- http//www.aarkstore.com/news